A drug infusion device with security base includes a reservoir, used for accommodating the drug to be infused, provided with a piston and a screw; a driving wheel, connected with the screw, driving the screw to push the piston forward by rotation; an infusion needle unit, including an infusion needle and a infusion needle holder, the infusion needle holder used to fixedly place the infusion needle; an adhesive patch, for attaching the infusion device module to the skin surface; and a security base, arranged on the bottom of the adhesive patch, provided with an infusion needle accommodating part, for accommodating the infusion needle when the infusion device is priming. The infusion needle accommodating part can accommodate the infusion needle protruding from the adhesive patch, preventing the infusion needle from stabbing the user.
A skin patch drug infusion device is disclosed. The skin patch drug infusion device includes an infusion mechanism module, the infusion mechanism module includes an infusion module and a circuit module, the circuit module includes: a circuit board or a three-dimensional circuit coated on the surface of part components, for supplying power to specific units; a power supply, for supplying power to the infusion device; an elastic conductor, provided with at least a protrusion, for electrically connecting the power supply to the specific connection end on the circuit board or three-dimensional circuit; a control mechanism module, electrically connected with the infusion mechanism module; and an adhesive patch, for attaching the infusion mechanism module and the control mechanism module to the skin surface. The elastic conductor is provided with protrusions.
Provided is an installation unit (100) of an analyte detection apparatus (104). A buckle structure of a parallel slider module (103) is in contact with an annular structure of the analyte detection apparatus (104), so that releasable connection is formed between the parallel slider module (103) and the analyte detection apparatus (104); when the parallel slider module (103) is located at a distal end, the analyte detection apparatus (104) is fixed on the parallel slider module (103), and after the parallel slider module (103) slides to a proximal end, the analyte detection apparatus (104) is automatically separated from the parallel slider module (103). The installation unit (100) features simple structure and high reliability and is convenient to use.
Provided is a drug infusion system with a graphical user interface, which comprises a detection apparatus (100), an infusion apparatus (102), and a control apparatus (101). The detection apparatus (100) is used for detecting a blood glucose value of a user, the infusion apparatus is used for infusing a drug into a user, and the control apparatus (101) is in wireless communication with the detection apparatus (100) and the infusion apparatus (102), and the control apparatus (101) controls drug delivery of the infusion apparatus (102). The control apparatus (101) is provided with a graphical user interface comprising a main screen, and the main screen comprises an insulin information display area and a blood glucose information display area. The insulin information display area comprises insulin infusion state information, and the user interface displays the insulin infusion state information in the form of a pattern (2021) and/or a text (2022). A user can visually know current insulin infusion state information and blood glucose information.
G16H 40/60 - ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
G16H 20/17 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
7.
MANAGEMENT DEVICE AND METHOD FOR DISPLAYING GLUCOSE INFORMATION
A management device for displaying glucose information. The screen of the management device is divided into the plurality of display areas, at least comprising a first display area for displaying the status of the management device, a second display area for displaying real-time glucose information, and a third display area for displaying historical glucose concentration information. The user can intuitively and easily get the glucose information in the body.
A61B 5/145 - Measuring characteristics of blood in vivo, e.g. gas concentration, pH-value
G16H 20/17 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
A skin patch drug infusion device includes an infusion mechanism module, the infusion mechanism module includes a reservoir, used for accommodating the drug to be infused, a screw and a piston connected with the screw are arranged inside; a driving wheel assembly, threadedly connected with the screw, wherein the driving wheel assembly includes a driving wheel body and a movable block, the driving wheel body and the movable block are operatively connected, when the movable block is in opened, the screw does not engage with the driving wheel assembly, and when the movable block is closed, the screw engages with the driving wheel assembly. The infusion mechanism module further includes a control mechanism module, electrically connected with the infusion mechanism module; and an adhesive patch, for attaching the infusion mechanism module and the control mechanism module to the skin surface.
A skin patch drug infusion device is provided. The device includes an infusion mechanism module, a control mechanism module and an adhesive patch. The infusion mechanism module includes an infusion module and a circuit module. The circuit module includes: a circuit board or a three-dimensional circuit coated on the surface of part components, for supplying power to specific units; a driving unit, for pushing the driving wheel of the infusion mechanism module to implement drug infusion; a conductive tower-spring, including a middle part with a small diameter and two end parts with a large diameter in the axial direction, for fixing the driving unit and electrically connecting the driving unit and the specific connection end on the circuit board or three-dimensional circuit. The control mechanism module is electrically connected with the infusion mechanism module. The adhesive patch is used for attaching the infusion mechanism module and the control mechanism module to the skin surface.
A drug infusion device with embedded power supply includes a drug reservoir, used for accommodating the drug to be infused, provided with a piston and a screw; a driving wheel, connected with the screw, driving the screw to push the piston forward by rotation; a power supply, used to supply power to the infusion device, including a power supply shell, a battery cell, electrolyte and a cover plate; a frame, used to carry the drug reservoir, the driving wheel, the power supply and electrical connection terminals of specific components, the power supply is electrically connected to the electrical connection terminals of specific components to realize power supply to the infusion device; a case, including an upper case and a lower case, for accommodating the drug reservoir, the driving wheel, the power supply and frame.
A skin patch drug infusion device includes an infusion mechanism module, the infusion mechanism module includes an infusion module and a circuit module, the circuit module includes: a circuit board or a three-dimensional circuit coated on the surface of part components, for supplying power to specific units; a power unit, for providing power to pull the driving wheel of the infusion mechanism module to implement drug infusion; a conductive platform, provided with a conductive platform protrusion, for electrically connecting the power unit to the specific connection end on the circuit board or three-dimensional circuit; a control mechanism module, electrically connected with the infusion mechanism module; and an adhesive patch, for attaching the infusion mechanism module and the control mechanism module to the skin surface.
An integrated skin patch artificial pancreas includes an infusion mechanism module, including a case, provided with multiple second electrical contacts exposed on the case and multiple second engaging portions; a control mechanism module, provided with multiple first electrical contacts exposed on the surface of the control mechanism module and multiple first engaging portions, the control mechanism module including an input end and an output end, and the input end including electrically connective regions for receiving signals of analyte data in the body fluid and an infusion tube (150), provided with multiple electrodes.
A skin patch drug infusion device includes an infusion mechanism module, the infusion mechanism module includes an upper case and a lower case; a control mechanism module, arranged on the lower case, and electrically connected with the infusion mechanism module; and an adhesive patch, including a tape and a protective film. The first side of the tape is fixedly connected with the lower case of the infusion mechanism module, and the second side opposite the first side of the tape is coated with a paste material, the protective film is fixed around the outer edge of the first side of the tape, the outer edge of the protective film contour corresponds to the outer edge of the tape, and the rockwell hardness of the protective film is higher than the tape.
44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services
Goods & Services
Medical clinic services; Hospital services; Health care; Nursing, medical; Telemedicine services; Therapy services; Health centre services; Health counselling; Remote monitoring of medical data for medical diagnosis and treatment; Rest home services; Dietary and nutritional advice; Rental of medical machines and apparatus; Medical clinics; Medical advisory services; Dietary and nutritional guidance; Providing medical information; Rental of medical apparatus and instruments; Medical counseling services; Massage services.
An enhanced drug infusion device includes a drug reservoir, used for accommodating the drug to be infused, provided with a piston and a screw; a driving wheel, connected with the screw, driving the screw to push the piston forward by rotation; a driving unit, driving the driving wheel to rotate; a power unit, connected with the driving unit, to offer power for the driving unit; a case, for accommodating the reservoir, the driving wheel, the driving unit and the power unit; and an adhesive patch , for attaching the infusion device to skin. The adhesive patch includes at least two layers of tape, the first side of the first layer of tape is fixedly connected with the bottom of the case, and the second side opposite to the first side of the first layer of tape is coated with an adhesive material.
A skin patch drug infusion device, includes a control mechanism module provided with multiple first engaging portions and a first electrical connection exposed on the surface of the control mechanism module; and an infusion mechanism module including a case, with a second electrical connection exposed on the surface of the case and second engaging portions that engaged with the first engaging portions; and an alarm, non-closed arranged in the control mechanism module. When the control mechanism module and the infusion mechanism module are assembled with each other, the first engaging portions and the second engaging portions are engaged, the first electrical connection and the corresponding second electrical connection are electrically connected to each other, thereby the control mechanism module and the infusion mechanism module are electrically connected to each other.
Disclosed is a patch-type drug infusion apparatus. The patch-type drug infusion apparatus comprises: a control structure, which is provided with a plurality of first electrical contacts exposed on a surface of the control structure; and an infusion structure, the infusion structure comprising a casing body, and the infusion structure being provided with a plurality of second electrical contacts exposed on a surface of the casing body; when the control structure and the infusion structure are assembled together, the first electrical contacts and the corresponding second electrical contacts are pressed together, thereby causing the control structure to be electrically connected to the infusion structure; and an end portion of the first electrical contacts is flush with the surface of the control structure or protrudes out from the surface of the control structure that is in contact with the first electrical contacts. When the control structure and the infusion structure are assembled together, the first electrical contacts and the second electrical contacts can have priority in establishing contact, so that the reliability of electrical connection of the control structure and the infusion structure is further improved.
A skin patch drug infusion system, includes: an infusion mechanism module, including: a reservoir, for accommodating a drug to be infused, and provided with a drug inlet and a drug outlet; an infusion needle, one end of the infusion needle communicated with a drug outlet of the reservoir, and the other end of the infusion needle is delivered subcutaneously to realize drug infusion; a control mechanism module, connected with the infusion mechanism module to control the drug infusion; a sensing module, operatively connected to the control mechanism module and used to sense or recognize the user's body movements, and different body movements representing different functional instructions, and according to the body movement sensed or recognized by the sensing module, the control mechanism module controlling the infusion mechanism module to execute corresponding functional instructions; and an adhesive patch, for attaching the infusion mechanism module.
A driving structure of a drug infusion device, includes at least one driving unit and at least one driving wheel; a linear actuator connected with the driving unit; a switch unit electrically connected with the linear actuator; a power supply, the power supply, the switch unit and the linear actuator electrically connected to form a power supply circuit; and a program unit, including a timer electrically connected to the switch unit, when the timer works, the switch unit is closed to turn on the power supply circuit, and the linear actuator is powered; when the timer stops working, the switch unit is opened to disconnect the power supply circuit, and the linear actuator stops being powered, which makes the infusion device have multiple different infusion modes and improves user experience.
A bilaterally driven drug infusion system, includes: an infusion unit, including a drug storage unit; a piston and a driving wheel respectively connected with a screw, the driving wheel, provided with wheel teeth, driving the screw movement by rotation, the piston arranged in the drug storage unit, the screw advancing the piston to move; a driving unit, cooperated with the driving wheel; a power unit, connected to the driving unit; a control unit, controlling the driving unit to output forces in two different directions on the driving unit; and sensing unit, operatively connected to the control unit and used to sense or recognize the user's body movements, and different body movements represent different functional instructions, and according to the body movement sensed or recognized by the sensing unit, the control unit controlling the infusion unit to execute corresponding functional instructions.
An analyte detection system, includes a bottom case housing, which is used for mounting to the surface of human skin; a sensor mounted on the bottom case housing for detecting the analyte parameter information; a transmitter unit including a transmitters shell, an internal circuit, a transmitter and a motion sensor, the transmitter sending the analyte parameter information to the outside world, the motion sensor connected to the internal circuit operationally, used for induction or identify the user's body movements. According to induction or recognition of body movements by the motion sensor, the internal circuit controls the sensor or the transmitter to execute the corresponding functional instructions to enhance the user experience.
A patch-type drug infusion device, includes a control structure provided with multiple first fastening portions and first electrical contacts; and an infusion structure, including a case, provided with multiple second electrical contacts and second fastening portions that cooperate with the first fastening portions, an outward extending portion provided on the case, and a block provided on the outside of the outward extending portion. The first fastening portions and the second fastening portions are fastened, making the control structure and the infusion structure assembled together, the first electrical contacts connect with the corresponding second electrical contacts. The block can prevent the control structure from detaching from the infusion structure.
A driving mechanism of a drug infusion device, includes at least one driving unit and at least one driving wheel, the driving unit, moving in the driving direction, driving the driving wheel to rotate; a linear actuator, electrically connected with the driving unit, pulling the driving unit to move in the driving direction after being powered; a switch unit group, including a first switch unit and a second switch unit, the first switch unit electrically connected with the linear actuator; a power supply, the power supply, the switch unit group and the linear actuator electrically connected to form a power supply circuit that supplies power to the linear actuator; when the linear actuator being powered, the driving unit implementing driving, and the driving unit triggering a first signal, indicating the end point of the driving direction.
A patch-type drug infusion device includes a control structure provided with multiple first fastening portions and first electrical contacts; and an infusion structure including a case, a power supply, a flexible circuit board, and an elastic conductor, and provided with multiple second electrical contacts and second fastening portions that cooperate with the first fastening portions. The first fastening portions and the second fastening portions are fastened, the first electrical contacts connect with the corresponding second electrical contacts, making the structure more compact and improving the space utilization rate inside the infusion structure.
A patch-type drug infusion device, includes a control structure provided with multiple first fastening portions and first electrical contacts; and an infusion structure including a case, with multiple second electrical contacts exposed on the surface of the case and second fastening portions that cooperate with the first fastening portions, when the control structure and the infusion structure are assembled with each other, the first fastening portions and the second fastening portions are fastened, the first electrical contacts and the corresponding second electrical contacts press against each other, thereby electrically connecting the control structure and the infusion structure, which helps to optimize the internal circuit design and improve the reliability of the electrical connection.
A compact patch-type drug infusion device includes a control structure provided with multiple first fastening portions and first electrical contacts; and an infusion structure including a case, a power supply, multiple three-dimensional circuits, and an elastic conductor, and provided with multiple second electrical contacts and second fastening portions that cooperate with the first fastening portions. The first fastening portions and the second fastening portions are fastened, the first electrical contacts connect with the corresponding second electrical contacts, making the structure more compact and improving the space utilization rate inside the infusion structure.
Provided is an energy-saving analyte detection system (10), which comprises an analyte detection device (102) and an auxiliary installer (101) for installing the analyte detection device (102) on the skin surface of a user. The analyte detection device (102) at least comprises a transmitter (1023) and a sensor (1022), wherein the transmitter (1023) comprises a battery (1025), a wake-up module (1026) and a working module (10231). The wake-up module (1026) comprises a processor (10262), a state switching component (10261) and a field effect transistor (10263). Before installation, the state switching component (10261) is in an open circuit, the processor (10262) is powered on, but is in a deep dormant state, and the field effect transistor (10263) is enabled to be in an open circuit; the transmitter (1023) does not transmit a signal to the outside. After the analyte detection device (102) is installed, the state switching component (10261) is in a closed circuit, the processor (10262) is converted into a working state, and the transmitter (1023) starts to transmit a signal to the outside. The system can save the energy consumption of the battery and prolong the service life of the analyte detection device.
A driving structure of a drug infusion device, includes at least one driving unit and at least one driving wheel; a linear actuator, electrically connected with the driving unit, pulling the driving unit to move in the driving direction after being powered; a power supply used to supply the power to the linear actuator; a program unit and a first switch unit. The power supply, the program unit, the first switch unit and the linear actuator are electrically connected, when the linear actuator is powered, the driving unit implements driving, and the driving unit triggers a first signal, indicating the end point of the driving direction, which reduces the power consumption of the infusion device.
A unilaterally driven drug infusion system, includes: an infusion unit, including a reservoir, a piston and a screw, the piston arranged in the reservoir; a driving unit including a rotating shaft and a driving member, the driving member including a driving end; a driving wheel provided with wheel teeth; a linear actuator and a reset unit respectively connected to the driving member; a control unit controlling the linear actuator or the reset unit to apply different driving powers on the driving member; and a sensing unit operatively connected to the control unit and used to sense or recognize the user's body movements, and different body movements represent different functional instructions, and according to the body movements sensed or recognized by the sensing unit. The control unit controls the infusion unit to execute corresponding functional instructions.
A61M 5/168 - Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters
G16H 20/17 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
A needle mechanism module for drug infusion device, includes: an infusion needle, provided with a front end and a rear end; a needle holder; provided with at least an auxiliary engaging part, the infusion needle being arranged on the needle holder, when the needle holder is at the working position, the rear end is inserted into the skin, and the front end is connected to the drug storage unit of the infusion device; an auxiliary engaging portion, arranged within the infusion device, engaged with the auxiliary engaging part to limit the needle holder at the working position; and a stopper, arranged on the housing of the infusion device, when the needle mechanism module is at intermediate position, the stopper limits the position of the needle holder, the front end is connected with the drug storage unit of the infusion device, to balance the internal and external pressures.
An integrated artificial pancreas with multiple infusion modes, includes: drug infusion unit; program unit comprising input end and output end, and the input end comprises a plurality of electrically connective regions for receiving signals of analyte data in the body fluid, after the output end is electrically connected to the power unit, the program unit controls whether the drug infusion unit delivers drugs; and an infusion cannula provided with at least two detecting electrodes, the infusion cannula is the drug infusion channel, the electrodes are disposed on the cannula wall. It takes only one insertion to perform both analyte detection and drug infusion.
An infusion needle structure of drug infusion device includes: an infusion needle including a front end and a back end; a needle holder provided with at least one auxiliary fastener; one fastening portion, arranged inside the infusion device, cooperates with the auxiliary fastener to lock the needle holder in the working position; an unlock hole provided on the needle holder or on the housing of the infusion device; and an unlock rod that is inserted into the unlock hole and pushed, thus releasing and resetting the needle holder. The infusion needle is able to reset and released when the infusion device is during replacement.
Disclosed herein is a highly integrated drug infusion device (100), comprising: an infusion unit (110) configured to deliver drugs; a program unit (120) comprising an input end (121) and an output end (122), and the input end (121) comprises a plurality of electrically connection areas for receiving the signal of analyte data in the body fluid, after the output end (122) is electrically connected to the infusion unit (110), and the program unit (120) controls the drug delivering of the infusion unit (110); an infusion cannula (130) provided with electrodes and electrode contact point; and a conductor (170), one end is fixed and electrically connected to the electrode contact point(PAD) (140), and the other end is slidably and electrically connected to the electrical connection area, when the infusion cannula (130) is installed in the working position, the infusion cannula (130) is connected with the infusion unit (110), the drug can be injected into the body through the infusion cannula (130), and the conductor (170) is electrically connected to the electrical connection area, inputting signal of analyte data in the body fluid to the program unit (120). The PAD (140) is no longer slidably connected to the electrical connection area and will not be damaged, thereby improving the stability of the electrical connection of the drug infusion device (100) and prolonging the service life.
A high-reliability analyte detection device, includes: a bottom shell ; a sensor, with the sensor being assembled on the bottom shell, the sensor including a signal output end and a detection end, wherein the signal output end is provided with at least two mutually insulated first electrical connection areas, and the signal output end is curved or bent toward the bottom surface of the bottom shell; a transmitter, with the transmitter and the bottom shell being engaged with each other, and the transmitter being provided with at least two mutually insulated second electrical connection areas which correspond to the first electrical connection areas, wherein the first electrical connection areas are electrically connected to the corresponding second electrical connection areas; and an elastic member, with the signal output end being in contact with the elastic member.
A61B 5/145 - Measuring characteristics of blood in vivo, e.g. gas concentration, pH-value
A61B 5/1473 - Measuring characteristics of blood in vivo, e.g. gas concentration, pH-value using chemical or electrochemical methods, e.g. by polarographic means invasive, e.g. introduced into the body by a catheter
A61B 5/00 - Measuring for diagnostic purposes ; Identification of persons
37.
CLOSED-LOOP ARTIFICIAL PANCREAS INSULIN INFUSION CONTROL SYSTEM
A closed-loop artificial pancreas insulin infusion control system, includes: a detection module; a program module is configured to obtain the insulin dose infused per day by users; an infusion module, connected to and controlled by the program module, is configured to infuse insulin required according to the data of the current insulin infusion dose; and a motion sensor configured to sense the user's physical activity status which is sent to the program module and is one of the variable factors of the total daily dose (TDD) algorithm or the current insulin infusion algorithm. This system automatically detect the physical condition of the user and accurately calculate the TDD value and the current insulin infusion dose, enhancing user experience.
A61B 5/11 - Measuring movement of the entire body or parts thereof, e.g. head or hand tremor or mobility of a limb
G16H 10/60 - ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
A highly integrated analyte detection device is provided. The transmitter is composed of a shell, a cover body, a circuit module and an electrical connection module. The circuit module is fixedly connected with the shell, one end of the electric connection module is fixedly connected with the circuit module, the other end extends to the outside through the through hole on the shell, and is electrically connected with other structural parts. The sealing material is filled between the electric connection module and the through hole, and the cover body and the shell are clamped together to form a seal for the circuit module, which makes the transmitter structure simpler. The shell and the circuit module can be processed separately and then assembled. The production process is less difficult and the production cost is reduced at the same time.
A61B 5/145 - Measuring characteristics of blood in vivo, e.g. gas concentration, pH-value
A61B 5/1468 - Measuring characteristics of blood in vivo, e.g. gas concentration, pH-value using chemical or electrochemical methods, e.g. by polarographic means
A61B 5/00 - Measuring for diagnostic purposes ; Identification of persons
A unilaterally driven drug infusion device includes: a reservoir, a piston and a screw, the piston connected with the screw and arranged in the reservoir; a driving unit including rotating shaft and driving member, and the driving member including driving end; driving wheel provided with wheel teeth; a linear actuator and a reset unit respectively connected to the driving member; and at least two blocking walls, arranged at one side of the driving unit to limit the advancing position of the driving unit. The infusion device is able to precisely control the rotation amplitude of the driving member and improve the infusion accuracy of the infusion device. The user or the closed-loop system is able to flexibly select different infusion modes to precisely control the body fluid level to meet the needs of the body, improving user experience.
An installation unit of an analyte detection device, includes: a sensor unit, which is provided near a front end of the installation unit; a trigger component, prior to starting the trigger component, the installation unit not performing an installation action; an auxiliary needle module, which is used to prick the in vivo part of a sensor under the skin; a parallel slider module, which is used to carry the sensor unit; a base, which is embedded in the installation unit from the front end of the installation unit; an elastic assembly, which is sleeved on the auxiliary needle module; and an outer casing, which is used to carry the trigger component, the auxiliary needle module, the parallel slider module, and the base. The installation unit has a simple and compact structure, a small size, low production and fabrication costs, and is convenient for users to use.
A61B 5/1473 - Measuring characteristics of blood in vivo, e.g. gas concentration, pH-value using chemical or electrochemical methods, e.g. by polarographic means invasive, e.g. introduced into the body by a catheter
A61B 5/145 - Measuring characteristics of blood in vivo, e.g. gas concentration, pH-value
41.
BODY FLUID ANALYTE DETECTION DEVICE AND CONTINUOUS GLUCOSE MONITORING DEVICE
A body fluid analyte detection device, includes: a transmitter, provided with at least one first clamping part; a bottom shell, provided with a second clamping part corresponding to the first clamping part, the transmitter being assembled on the bottom shell by mutual snap fitting of the first clamping part and the second clamping part, the bottom shell including a fixing part and a force application part, and the fixing part being fixed and applying a force to the force application part in a direction to disable the bottom shell, so that the first clamping part and the second clamping part are separated from each other, and then the bottom shell and the transmitter are separated; a battery, used for supplying power to the transmitter; a sensor, used for detecting body fluid analyte parameter information and electrically connected to the transmitter to transmit a parameter signal.
A body fluid analyte detection apparatus is provided. Applying a force to a force applying portion of a bottom case in one direction can make the bottom case fail, and then separate the bottom case and a transmitter from each other. Before the bottom case is mounted to a human body, the bottom case is fixed together with a mounting unit by means of a snap-fit portion. Operation steps of a user when separating the bottom case from the transmitter are reduced, and the failure rate of the bottom case before being mounted to the human body is also reduced, thereby improving the user experience, and enhancing the reliability of the body fluid analyte detection apparatus.
A drug infusion device with integrated power supply comprises a drug reservoir, used for accommodating the drug to be infused, provided with a piston and a screw; a driving wheel, connected with the screw, driving the screw to push the pistion forward by rotation; a power supply, used to supply power to the infusion device, including a power supply shell, a power supply cell, electrolyte and a cover plate; and a case, including an upper case and a lower case, for accommodating the drug reservoir, the drive wheel and the power supply; the power supply shell is integrated with the lower and/or the cover plate is integrated with the upper case.
Disclosed is a highly integrated drug infusion device, comprising: a drug reservoir 112, used for accommodating the drug to be infused, provided with a piston and a screw; a driving wheel 114, connected with the screw, driving the screw to push the piston forward by rotation; a power supply 113, used to supply power to the infusion device; and a case, including an upper case 111a and a lower case 111b, for accommodating the drug reservoir 112, the drive wheel 114 and the power supply 113; wherein a three dimensional circuit 136 is provided on the case, and the three dimensional circuit 136 is electrically connected to the power supply 113 to supply power to the infusion device. The three dimensional circuit 136 is arranged on the case and does not occupy the internal space of the infusion device, which can make the internal arrangement of the infusion device more compact and further reduce the volume of the infusion device.
A unidirectional-driven drug infusion device, includes: a reservoir, a piston and a screw, the piston is arranged in the reservoir; a driving module which includes at least one driving wheel and at least one driving arm that cooperate with each other, the circumferential surface of the driving wheel is provided with wheel teeth; a power module coupled to the driving arm; a control module, connected to the power module, controls the power module to apply different driving powers to the driving arm, making the driving arm perform linear reciprocating motion; and a friction member which is in contact with the surface of the driving wheel. This device can fully utilize the internal space of the infusion device, and its weight and volume is reduced.
The invention discloses a kind of positive electrode plate for medical device battery and its preparation method, using dry mix and wet mixing with the combination of coating method, due to the blending can reduce the conductive powder material distribution and the uneven binding phenomenon, help build of conductive network, increase the porosity of the anode material, reducing the positive pole piece of polarization, the large current pulse discharge capacity of the battery is improved.
A bilaterally driven closed-loop artificial pancreas, includes: a detection module; an infusion module, the infusion module includes: a drug storage unit; a screw and a driving wheel provided with wheel teeth, the driving wheel driving the screw and the screw pushing a piston; a driving unit cooperating with the driving wheel, the driving unit including at least two driving portions; a power unit connected to the driving unit, the power unit outputting two forces in two directions on the driving unit; and a program module. The power unit is controlled by the program module. The artificial pancreas has higher infusion efficiency and can enhance user experience.
A61M 5/14 - Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
G16H 20/17 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
A bilateral-driven patch-type drug infusion device comprises: an infusion unit; a driving wheel drives the screw to move by rotation, pushing the piston forward; a driving unit includes at least two driving portions, the driving unit pivots around a pivot shaft, driving different driving portions in different direction; and an infusion tube structure, which includes a base and an infusion needle, and the base includes an initial position (L), a working position (N), and an intermediate position (M). The driving unit can drive the driving wheel in two directions for infusion drug, making the infusion unit have multiple infusion modes, enhancing user experience.
A bilaterally driven closed-loop artificial pancreas, includes: a detection module; an infusion module, including: a drug storage unit; a screw and a driving wheel provided with wheel teeth, the driving wheel driving the screw and the screw pushing a piston; a driving unit cooperating with the driving wheel, the driving unit including at least two driving portions; a power unit connected to the driving unit, the power unit outputting two forces in two directions on the driving unit; and a program module imported the total daily dose algorithm and the current insulin infusion algorithm. The artificial pancreas can accurately calculate the TDD value and the current insulin infusion dose, and enhance user experience.
A bilaterally driven intelligent control infusion device, comprising: infusion unit, the infusion unit comprises a drug storage unit, a piston and a rigid screw, the piston is arranged in the drug storage unit, a metal piece arranged on the piston, fixedly connected to the rigid screw; a driving wheel, provided with wheel teeth, drives the screw movement by rotation, the screw advances the piston to move; a driving unit cooperating with the driving wheel; and a power unit, connected to the driving unit, outputs forces in two different directions on the driving unit to lead driving unit to pivot; a position detector, interacted with the metal piece to generate signal; a program unit, connected to the infusion unit, convert the received signal into the piston position information and can control the driving unit to operate with different infusion rate according to requirements.
BB; and an infusion module (102), connected to and controlled by the program module (101), is configured to infuse insulin according to the corresponding output instructions calculated by the rPID algorithm. The simple and robust characteristics of PID algorithm can be retained, and giving the rPID algorithm the advantages of precision and flexibility, realizing precise control for closed-loop artificial pancreas insulin infusion system.
1212333122, the final infusion result is more accurate and reliable, realising precise control of the closed-loop artificial pancreatic insulin infusion control system.
A closed-loop artificial pancreas insulin infusion personalized control system includes: a detection module (100) configured to detect the current blood glucose level G continuously; a program module (101), preset with an algorithm for calculating insulin infusion instructions, an adaptive unit for adjusting the gain coefficient of the algorithm according to the user's weight BW, and a preset target blood glucose value GB; and an infusion module (102), connected to and controlled by the program module (101), is configured to infuse insulin according to the corresponding infusion instructions calculated by the algorithm. The system can adjust the gain coefficient of the corresponding algorithm according to the user's weight, which is convenient for personalized settings according to the actual situation of the user, and can better meet the real needs of the user and improve user experience.
1212333122, the final infusion result is more accurate and reliable, realizing precise control of the closed-loop artificial pancreatic insulin infusion control system.
A closed-loop artificial pancreas drug infusion control system (100), includes an infusion module (110), configured to deliver drugs; a program module (120), comprising an input end (121) and an output end (122), and the input end (121) comprising a plurality of electrically connective regions (121a, 121b) for receiving the current blood glucose level, the program module (120) further preset with a hybrid artificial pancreas algorithm, used for calculating the insulin infusion amount required by the user, the hybrid artificial pancreas algorithm includes a cPID algorithm and/or a cMPC algorithm, where the input of the cPID algorithm is the intermediate value of the MPC algorithm, and the input of the cMPC algorithm is the output value of the PID algorithm; after the output end (122) is electrically connected to the infusion module (110), the program module (120) controls the infusion module (110) to output the drug according to the calculated amount of drug required by the user; and an infusion cannula (130), provided with at least two electrodes (171, 172, 271, 272, 371, 372, 373, 471, 472), the infusion cannula (130) is the drug infusion channel, the electrodes (171, 172, 271, 272, 371, 372, 373, 471, 472) are disposed on the cannula wall (132), when the infusion cannula (130) is installed to the working position, the infusion cannula (130) is connected with the infusion module (110), the drug can then be injected into the body through the infusion cannula (130), and the different electrodes (171, 172, 271, 272, 371, 372, 373, 471, 472) are electrically connected to different electrically connective regions (121a, 121b) respectively, inputting signals of blood glucose level to the program module (120). The algorithm is used to realize the precise control of the closed-loop artificial pancreas drug infusion control system (100).
A61M 5/00 - Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm rests
56.
FULLY CLOSED-LOOP ARTIFICIAL PANCREAS DRUG INFUSION CONTROL SYSTEM
A fully closed-loop artificial pancreas drug infusion control system includes a program module (101), at least one detection module (100), a hypoglycemic drug infusion module (104) and an anti-hypoglycemic drug infusion module (103). The program module (101) is preset with an algorithm. The detection module (100) detects the blood glucose level, the hypoglycemic drug infusion module (104) performs hypoglycemic drug infusion according to the infusion instruction calculated by the algorithm, and the anti-hypoglycemic drug infusion module (103) performs anti-hypoglycemic drug infusion according to the infusion instruction calculated by the algorithm, realizing full closed-loop control of drug infusion in artificial pancreas system.
A61B 5/145 - Measuring characteristics of blood in vivo, e.g. gas concentration, pH-value
A61B 5/1468 - Measuring characteristics of blood in vivo, e.g. gas concentration, pH-value using chemical or electrochemical methods, e.g. by polarographic means
57.
CLOSED-LOOP ARTIFICIAL PANCREATIC INSULIN INFUSION CONTROL SYSTEM
A closed-loop artificial pancreatic insulin infusion control system, comprising: a monitoring module (100), an infusion module (102) and an electronic module (103), wherein the monitoring module (100), the infusion module (102) and the electronic module (103) each are provided with a control unit, and a corresponding first algorithm, second algorithm and third algorithm are preset in each of the control units; and when different priority conditions are met, the currently required insulin infusion information is determined by different modules, and the infusion module performs insulin infusion. Therefore, the closed-loop artificial pancreatic insulin infusion control system can automatically switch control units according to different conditions, thereby avoiding the situation in which a certain module of a setting program unit cannot work normally and thus affecting the user experience, and even posing a safety risk to a user.
A closed-loop artificial pancreatic insulin infusion control system, comprising: a detection module (100) and an infusion module (102). A detection control unit is provided in the detection module (100); an infusion control unit is provided in the infusion module; at least one of the detection module (100) and the infusion module (102) is provided with a calculation control unit (1, 2) for calculating insulin infusion information and/or further processing different insulin infusion information. Therefore, automatic switching between the control units can be achieved according to different conditions in the closed-loop artificial pancreatic insulin infusion control system, the situation that the user experience is affected, or even a safety risk is brought to a user due to the fact that a certain module of a program unit cannot work normally is avoided, moreover, the situation that the system needs to be integrally replaced when part of functions of part of components fails is avoided, and the utilization rate of the components of a closed-loop artificial pancreas is improved.
BB, the rMPC algorithm calculates insulin infusion instructions based on blood glucose risk; and an infusion module (102), connected to the program module (101), and is controlled by the program module (101) to infuse insulin according to the corresponding output instructions calculated by the rMPC algorithm. The system is preset with a rMPC algorithm, which converts the asymmetric blood glucose in the original physical space to the approximately symmetric blood glucose risk in the risk space, the recent changes of blood glucose and the asymmetry of distribution are taken into account in the rMPC algorithm, giving the rMPC algorithm the advantages of precision and flexibility, realizing precise control for closed-loop artificial pancreas insulin infusion system.
A61M 5/172 - Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters electrical or electronic
A61B 5/145 - Measuring characteristics of blood in vivo, e.g. gas concentration, pH-value
G16H 20/17 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
60.
CLOSED-LOOP ARTIFICIAL PANCREAS INSULIN MULTI-DRUG CONTROL SYSTEM
A closed-loop artificial pancreas insulin infusion control system is provided, including: a detection module (100) configured to the current blood glucose level; a program module (101), connected to the detection module (100), preset with one or more of rMPC algorithm, rPID algorithm or compound artificial pancreas algorithm; and an infusion module (102), connected to the program module (101), can perform anti-hypoglycemic drugs and/or hypoglycemic drugs infusion, the program module (101) controls the infusion module (102) to infuse corresponding drugs, according to the corresponding drug infusion instructions, which is calculated by the rMPC algorithm, rPID algorithm or compound artificial pancreas algorithm. The system is preset with one or more of the rMPC algorithm the rPID algorithm or compound artificial pancreas algorithm, which converts the asymmetric blood glucose in the original physical space to the approximately symmetric blood glucose risk in the risk space, making full use of the advantages of rPID algorithm and rMPC algorithm to face complex scenarios, so that the artificial pancreas can provide reliable insulin infusion under various conditions, and blood glucose can reach the ideal level at the expected time, realizing precise control for closed-loop artificial pancreas insulin infusion system.
Closed-loop artificial pancreas insulin infusion control system, includes: a detection module (100,200), configured to detect the current blood glucose level continuously, further provided with a detection processing unit (1001,2001), which preset with an algorithm, and the algorithm calculates the current required insulin infusion amount according to the current blood glucose level; and an infusion module (102,202), connected to the detection module (100,200), the detection module (100,200) sends the current required insulin infusion amount to the infusion module (102,202), and the infusion module (102,202) performs insulin infusion according to the current required insulin infusion amount. After the current blood glucose level is detected, the current required insulin infusion amount is directly calculated without sending it to others, which make the infusion result more accurate and reliable.
A61B 5/145 - Measuring characteristics of blood in vivo, e.g. gas concentration, pH-value
A61M 5/172 - Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters electrical or electronic
G16H 20/17 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
62.
CLOSED-LOOP ARTIFICIAL PANCREAS DRUG INFUSION CONTROL SYSTEM
Closed-loop artificial pancreas drug infusion control system (100), including an infusion module (110), configured to deliver drugs; a program module (120), comprising input end (121) and output end (122), and the input end (121) comprising a plurality of electrically connective regions (121a, 121b) for receiving the current blood glucose level, the program module (120) further preseted with an algorithm, and the algorithm is one or more of rMPC algorithm, rPID algorithm or compound artificial pancreas algorithm, after the output end (122) is electrically connected to the infusion module (110), according to the received current blood glucose level, the algorithm calculates the amount of drug required by the user, and the program module (120) controls the infusion module (110) to output the drug according to the calculated amount of drug required by the user; an infusion cannula (130) with conductive areas, the infusion cannula (130) is the drug infusion channel; and a plurality of electrodes for detecting the blood glucose level, the electrode comprising conductive-area electrodes (171) and cannula-wall electrodes (172), the conductive area of the infusion cannula (130) being at least as a conductive-area electrode (171), and one or more cannula-wall electrodes (171) being located on/in the wall of the infusion cannula (130), when the infusion cannula (130) is installed to the working position, the infusion cannula (130) is connected with the infusion module (110), the drug can be injected into the body through the infusion cannula (130), and the different electrodes (171,172) are electrically connected to different electrically connective regions (121a,121b) respectively, inputting the current blood glucose level to the program module (120). The algorithm is used to realize the precise control of the closed-loop artificial pancreas drug infusion system.
A61M 5/172 - Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters electrical or electronic
A61B 5/145 - Measuring characteristics of blood in vivo, e.g. gas concentration, pH-value
G16H 20/17 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
63.
CLOSED-LOOP ARTIFICIAL PANCREAS DRUG INFUSION CONTROL SYSTEM
A closed-loop artificial pancreas drug infusion control system (100), including an infusion module (110), configured to deliver drugs; a program module (120), comprising input end (121) and output end (122), and the input end (121) comprising a plurality of electrically connective regions (121a, 121b) for receiving the current blood glucose level, the program module (120) further presets with an algorithm, and the algorithm is one or more of rMPC algorithm, rPID algorithm or compound artificial pancreas algorithm, after the output end (122) is electrically connected to the infusion module (110), according to the received current blood glucose level, the algorithm calculates the amount of drug required by the user, and the program module (120) controls the infusion module (110) to output the drug according to the calculated amount of drug required by the user; and an infusion cannula (130) provided with at least two electrodes (171,172), the infusion cannula (130) is the drug infusion channel, the electrodes (171,172) are disposed on the cannula wall (132), when the infusion cannula (130) is installed to the working position, the infusion cannula (130) is connected with the infusion module (110), the drug can then be injected into the body through the infusion cannula (130), and the different electrodes (171,172) are electrically connected to different electrically connective regions (121a, 121b) respectively, inputting signal of blood glucose level to the program module (120). The algorithm is used to realize the precise control of the closed-loop artificial pancreas drug infusion system (100).
A closed-loop artificial pancreas insulin infusion control system, including a detection module (100), configured to detect the current blood glucose level G continuously; a program module (101), connected to the detection module (100), and preset with a hybrid artificial pancreas algorithm, used for calculating the insulin infusion amount required by the user, the hybrid artificial pancreas algorithm includes a cPID algorithm and/or a cMPC algorithm, where the input of the cPID algorithm is the intermediate value of the MPC algorithm, and the input of the cMPC algorithm is the output value of the PID algorithm; and an infusion module (102), connected to the program module (101), and is controlled by the program module (101) to infuse insulin according to the insulin infusion amount calculated by the hybrid artificial pancreas algorithm. Through the in-depth combination of PID algorithm and MPC algorithm, make full use of the advantages of PID algorithm and MPC algorithm to make the infusion result more accurate and reliable, and realize the precise control of the closed-loop artificial pancreatic insulin infusion system.
A closed-loop artificial pancreas drug infusion control system (100), including an infusion module (100), configured to deliver drugs; a program module (120), comprising input end (121) and output end (122), and the input end (121)comprising a plurality of electrically connective regions (121a, 121b) for receiving the current blood glucose level, the program module (120) further preset with a hybrid artificial pancreas algorithm, used for calculating the insulin infusion amount required by the user, the hybrid artificial pancreas algorithm includes a cPID algorithm and/or a cMPC algorithm, where the input of the cPID algorithm is the intermediate value of the MPC algorithm, and the input of the cMPC algorithm is the output value of the PID algorithm, after the output end (122) is electrically connected to the infusion module (110), the program module (120) controls the infusion module (110) to output the drug according to the calculated amount of drug required by the user; an infusion cannula (130) with conductive area (s), the infusion cannula (130) is the drug infusion channel; and a plurality of electrodes (171, 172) for detecting the blood glucose level, the electrodes (171, 172) comprising conductive-area electrode (s) (171) and cannula-wall electrode (s) (172), the conductive area of the infusion cannula (130) being at least as a conductive-area electrode (171), and one or more cannula-wall electrodes (172) being located on/in the wall of the infusion cannula (130), when the infusion cannula (130) is installed to the working position, the infusion cannula (130) is connected with the infusion module (110), the drug can be injected into the body through the infusion cannula (130), and the different electrodes (171, 172) are electrically connected to different electrically connective regions (121a, 121b) respectively, inputting the current blood glucose level to the program module (120). Through the in-depth combination of PID algorithm and MPC algorithm, make full use of the advantages of PID algorithm and MPC algorithm to make the infusion result more accurate and reliable, and realize the precise control of the closed-loop artificial pancreatic drug infusion system (100).
An installation unit of an analyte detection device comprises a housing (101). A parallel slider module (103) is arranged inside the housing (101) and can slide relative to the housing (101). An analyte detection device (104) is arranged at the front end of the parallel slider module (103). The analyte detection device (104) comprises a shell (1041), a transmitter, a sensor (1042) and an internal circuit arranged in the shell (1041) and electrically coupled with the sensor (1042). The shell (1041) connects with the parallel slider module (103) releasably. An auxiliary-needle module (105) is used to pierce the sensor (1042) under the use's skin. When a triggering module (106) moves towards the near end relative to the housing (101), the installation action is implemented. An elastic module (107) is used to provide the elastic force required to implement the installation action. When the installation action is implemented, the parallel slider module (103) and the analyte detection device (104) slide to the near end relative to the shell, and at a predetermined position, the connection between the shell and the parallel slider module (103) is relieved, and the analyte detection device (104) is separated from the parallel slider module (103).
An installation unit (100) of analyte detection device, comprises a housing (101) provided with a slot (1013) and a first buckle (1012), the slot (1013) comprises a first slot point (10141) and a second slot point (10142); a parallel slider module (103) provided with a second buckle (1033) coupled with the first buckle (1012); a triggering module (106) provide with a lug (1062) corresponding to the slot (1013) and a fixed buckle (1061) corresponding to the first buckle (1012). When the lug (1062) is located in the first slot point (10141), the fixed buckle (1061) is in contact with the first buckle (1012), and the installation unit (100) does not implement installation action. When the triggering module (106) moves towards the far end relative to the housing (101), and the lug (1062) enters the second slot point (10142), the fixed buckle (1061) cancels the contact with the first buckle (1012), and the coupling between the first buckle (1012) and the second buckle (1033) is released. The installation unit (100) implements the installation action, which is simple in structure and convenient in use.
A circuit embedded analyte detection device comprises shell (10, 20, 30), which comprises an upper outer shell (11, 21, 31) and a lower outer shell (12, 22, 32), and a through-hole (111, 211, 311) is arranged on the upper outer shell (11, 21, 31). The electronic circuit is arranged inside the upper outer shell (11, 21, 31) or the lower outer shell (12, 22, 32), which comprises at least one electronic component.The electronic components comprise at least a transmitter antenna (131, 231, 331) for communication with external equipment. The sensor (15, 25, 35) is used to obtain the parameter information of analyte in the user's body. And battery, used to power the electronic circuit.
A61B 5/145 - Measuring characteristics of blood in vivo, e.g. gas concentration, pH-value
H01M 50/109 - Primary casings, jackets or wrappings of a single cell or a single battery characterised by their shape or physical structure of button or coin shape
A compact analyte detection device includes a housing (10), provide with a circuit board (13), a battery (14) and a sensor (15). The housing (10) includes a first housing (11) and a second housing (12), and the sensor (15) is arranged in the first housing (11). The sensor (15) includes an in-vivo portion (152) and an in-vitro portion (151), the in-vitro portion (151) electrically connected to the circuit board (13) by an electrical connector (16), the in-vivo potion (152) passed through the first housing (11) to the outside. A transmitter antenna is provided on the circuit board (13), and the transmitter antenna is used to communicate with external equipment. The circuit board (13), the battery (14) and the in-vitro portion (151) of the sensor (15) are all arranged in the closed space formed by the first housing (11), the second housing (12) and the in-vivo portion (152) of the sensor (15), making the analyte detection device with a simple and a compact layout, which is beneficial to the miniaturization development of the analyte detection device.
A integrated analyte detection device includes a housing (10), provided with a circuit board (13), a battery (14) and a sensor (15). The housing (10) includes a first housing (11) and a second housing (12). The sensor (15) is integrated with the circuit board (13). The sensor (15) includes an in-vivo portion (152) and an in-vitro portion (151), and the in-vivo potion (152) passed through the first housing (11) to the outside. And a transmitter antenna is provided on the circuit board (13), and the transmitter antenna is used to communicate with external equipment. The integrated circuit board (13) and the sensor (15) improve the reliability of the electrical connection between the sensor (15) and the circuit board (13), reduce the number of components in the analyte detection device, thereby reduce the complexity of the internal design of the analyte detection device, and optimize the internal design of the analyte detection device.
An analyte detection device (102) comprises a shell (1021), a sensor (1022), a transmitter (1023), a battery (1025), a memory (1027), and a processor (1028). The sensor comprises an internal part (10222) and an external part (10221). The internal part (10222) is used to penetrate into a user's subcutaneous skin to obtain a first parameter value. At least one predetermined pair-data set composed of the first parameter value and a second parameter value is pre stored in the memory (1027). The second parameter value is associated with the in vivo analyte parameter information. The processor (1028) is programmed to call predetermined pair-data set from the memory, and obtain the second parameter value based on the first parameter by indexed. The transmitter (1023) is used to transmit the first parameter value and/or the second parameter value to a remote equipment. The battery (1025) is used to provide electric energy.
An analyte detection device and detection method. The predetermined pair-data set is pre stored in the memory. The predetermined pair-data includes the range value composed of the mean value of the adjacent first parameter values and the second parameter value. After the sensor penetrates the user's skin to obtain the first parameter value, the processor calls the predetermined pair-data from the memory, judges the interval range in which the first parameter value falls, and obtains the second parameter value by index in the predetermined pair-data, the preset calibration function is no longer needed to calculate the second parameter value according to the first parameter value, which reduces the error of the second parameter value and improves the reliability of the analyte detection system.
A calibration free analyte detection device (102, 202, 302) is disclosed. At least one predetermined pair-data set composed of the first parameter value and the second parameter value and the predetermined calibration function based on the time parameter are pre stored in the memory. After a sensor (1022, 2022, 3022) penetrates into the user's skin to obtain the first parameter value, the processor calls the predetermined pair-data set and the predetermined calibration function from the memory and obtains the second parameter value based on the first parameter value by index, the predetermined pair-data set is adjusted through the predetermined calibration function for the next detection and retrieval. The predetermined pair-data set is adjusted with the use time, which reduces the error of the second parameter value and improves the reliability of the analyte detection device (102, 202, 302).
A sensor calibration method comprises: providing a lot of sensors which are tested before production to obtain the summary pair-data set D i, classifying and dividing the summary pair-data set to obtain the typical pair-data sets D j, and storing them in the computer; during production, testing the small number of pair-data of sensors to be delivered, inputting the small number of pair-data into the computer, and obtaining the closest typical pair-data set to the small number of pair-data through calculation, the typical pair-data set can be used as the predetermined pair-data of the sensor to be delivered, and the preset predetermined calibration function is no longer required, which improves the calibration efficiency of the sensor, reduces the production time, and improves the reliability of the sensor.
The invention discloses a sensor calibration method, during production, some sample sensors are taken out from a lot of sensors for testing, to obtain the sample pair-data composed of the first test parameter value and the second parameter value. After averaging the first test parameter value, the range value composed of the average first test parameter value of the sample or the average value of the average first test parameter value of adjacent samples is given as the first parameter value of the lot, to obtain the predetermined pair-data set of the lot, and the preset predetermined calibration function is no longer required, which improves the calibration efficiency of sensors, reduces the production time, and improves the reliability of sensors.
The invention discloses a sensor calibration method. A lot of sensors are tested before production to obtain the summary pair-data set, classify and divide the summary pair-data set to obtain the typical pair-data sets, and store them in the computer. During production, test small number of pair-data of sensors to be delivered, input the small number of pair-data into the computer, and obtain the closest typical pair-data set to the small number of pair-data and difference between them through calculation, and then adjust the closest typical pair-data set based on the difference, and the adjusted typical data set can be used as the predetermined pair-data of the sensor to be delivered, and the preset predetermined calibration function is no longer needed, which improves the calibration efficiency of the sensor, reduces the production time, and reduces the difference between the actual sensitivity of the sensor and the predetermined pair-data caused by the difference of the physical characteristics of the sensor, and improves the reliability of the sensor.
An installation unit (100) of analyte detection device (104), which comprises the housing (101), the protective cover (102) and the label (108). The protective cover (102) comprises an outer cover (1021) and an inner cover (1022). The outer ring (1081) of the label (108) is fixed on the near end plane (10213) of the outer cover (1021), the inner ring (1082) is fixed on the near end plane (10225) of the inner cover (1022), and the inner ring (1082) of the label (108) is connected with the outer ring (1081) through the easy tear seam (1083). Before using the installation unit (100), the outer cover (1021) and inner cover (1022) remain fixed relative to the housing (101). When using the installation unit (100), the inner cover (1022) and inner ring (1082) of label (108) remain fixed relative to the housing (101), and the outer cover (1021) and outer ring (1081) of label (108) rotate relative to the housing (101) to damage the easy tear seam (1083). After the easy tear seam (1083) is damaged, it cannot be restored. The user can judge whether the protective cover (102) of the installation unit (100) has been opened through the state of the easy tear seam (1083), so as to avoid using the contaminated analyte detection device (104).
A61B 5/145 - Measuring characteristics of blood in vivo, e.g. gas concentration, pH-value
B65D 49/12 - Arrangements or devices for preventing refilling of containers by destroying, in the act of opening the container, an integral portion thereof
78.
SYSTEM AND METHOD FOR REALIZING COMMUNICATION CONNECTION OF ANALYTE DETECTION DEVICE
System and method for realizing communication connection of analyte detection device are disclosed. When the communication connection is not established and the communication connection has been established, the analyte detection device transmits two different signals respectively, namely the first signal and the second signal. The remote equipment searches and identifies the nearby signals, and executes different communication connection procedures according to the signals, When only one first signal is recognized by the remote equipment, it can be judged that the analyte detection device transmitting the signal is the analyte detection device to be established with communication connection, and the communication connection can be established directly without the user manually inputting or scanning the equipment code, which simplifies the process of establishing the communication connection, avoids the user inputting or scanning the wrong equipment code, and improves the user experience.
The invention discloses the communication system of analyte detection device, which comprises the analyte detection device and the remote equipment. The analyte detection device transmits signals, and the remote equipment is used to search and identify nearby signals, establish the communication connection with the analyte detection device and perform data interaction. The data interaction mode can be adjusted according to the actual use situation, and the battery energy consumption is reduced while transmitting the analyte parameter information, it is conducive to the long-time work of the system and improves the user experience.
Disclosed is an analyte sensor fixing device. Before an analyte detection device is installed, a sensor is enveloped in an auxiliary needle, an elastic pad is sleeved outside the auxiliary needle, and the elastic pad defines the sensor in the auxiliary needle. When internal parts in an installing unit swing in the installation process, the sensor does not get rid of the envelope of the auxiliary needle, and at the same time the sensor is not bent. Therefore, the sensor can be smoothly pricked under the skin along with the auxiliary needle, thereby improving the detection reliability of the analyte detection device.
An installation unit (100) of the analyte detection device and use method. The installation unit (100) comprises: a housing (101), comprising at least two first buckles (1012); a parallel slider module (103), which is provided with the second buckles (1033) corresponding to the first buckles (1012), and the first buckles (1012) are separately coupled with the second buckles (1033); an analyte detection device (104); an auxiliary-needle module (105); an triggering module (106), when the triggering module (106) moves to the far end relative to the housing (101), it cancels the coupling of the first buckles (1012) and the second buckles (1033) to implement the installation action; and an elastic module (107). When using the installation unit (100), the user only needs to attach the near end of the installation unit (100) to the skin surface and press the housing (101) at the far end to complete the installation of the analyte detection device, which is simple in structure and convenient in use.
An installation unit of an analyte detection device comprises a housing (101) provided with a limit slot (1013). A parallel slider module (103) is provided with a T-shaped structure (1035). The T-shaped structure (1035) comprises a horizontal part and a vertical part. The horizontal part comprises a T-shaped-structure slider (10351) located in the limit slot (1013). An analyte detection device (104) is arranged at the front end of the parallel slider module (103). The analyte detection device (104) comprises a shell (1041), a transmitter, a sensor (1042) and an internal circuit arranged in the shell (1041) and electrically coupled with the sensor (1042). An auxiliary-needle module (105) is used to pierce the sensor (1042) under the use's skin. When a triggering module (106) moves towards the near end relative to the housing (101), the installation action is implemented. An elastic module (107) is used to provide the elastic force required to implement the installation action.
The invention discloses an analyte detection system, comprising an auxiliary installer (101) and an analyte detection device (102), before use, the analyte detection device (102) is in dormant state and transmits signal to the outside equipment at the first frequency, when mounted to the host skin surface by the auxiliary installer (101), the wake-up module (1026) wakes up the analyte detection device (102) according to the triggering conditions, and the analyte detection device (102) enters the working state, transmits signal to the outside equipment at the second frequency, and establishes real-time communication with the outside equipment, the first frequency is less than the second frequency, which can improve user experience while reducing battery energy consumption and ensuring the life of analyte detection device (102).
A61B 5/145 - Measuring characteristics of blood in vivo, e.g. gas concentration, pH-value
A61B 5/05 - Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves
An installation unit (100) of analyte detection device, comprises: a housing (101), provided with an auxiliary-needle limit slot (1015); a paralled slider module (103), the far end face of which is provided with the slider-buckle (10321); an analyte detection device (104), located at the front end of the parallel slider module (103); and an auxiliary-needle module (105). When implementing the installation action, the auxiliary-needle module (105) moves to the near end along with the parallel slider module (103) relative to the housing (101). The auxiliary-needle (1052) inserts the sensor under the skin until the slider-buckle (10321) is separated from the auxiliary-needle limit slot (1015), the auxiliary-needle slide block (10511) returns back to the initial position, and the auxiliary-needle (1052) retracts back into the housing (101) to avoid unnecessary injury. The installation unit (100) has simple structure, high reliability and convenient use.
The invention provides an analyte detection device with battery and shell integrated. The battery cavity (14) is installed in the outer shell (10), the battery cavity (14) comprises the cavity shell (141), the diaphragm (142), the electrolyte (143), the anode plate (144), cathode plate (145) and the conductive strip (146), the electrolyte isolation layer (147) is also arranged inside the cavity shell (141), to form the structure of battery and outer shell (10) integration, the shape and size of the analyte detection device are no longer limited by the shape and size of the shell of the button battery, and the shape and size of the battery cavity (14) can be optimized according to the miniaturization design requirements of the analyte detection device to improve user experience.
An analyte detection device comprises: an outer shell (10, 20), a circuit board (13, 23) and a battery cavity (14, 24). The battery cavity (14, 24) comprises a cavity shell (141, 241), a diaphragm (142, 242), electrolyte (143, 243), an anode plate (144, 244), a cathode plate (145, 245) and a conductive strip (146, 246), an electrolyte isolation layer (147, 247) is also arranged inside the cavity shell (141, 241), an upper cover shell (1411, 2411) of the cavity shell (141, 241) is integrated with the circuit board (13, 23). The shape and size of the battery cavity (14, 24) can be optimized according to the miniaturization design requirements of the analyte detection device to improve user experience.
An analyte detection device (102, 202, 302) is provided. A first predetermined pair-data set and a second predetermined pair-data set composed of a first parameter value and a second parameter value are prestored in a memory (1027). The first predetermined pair-data set has at least a time parameter difference relative to the second predetermined pair-data set. After a sensor (1022) penetrates a user's skin to obtain the first parameter value, a processor (1028) calls the first predetermined pair-data set from the memory (1027) in a first time period, and then calls the second predetermined pair-data set from the memory (1027) in a second time period, and the second parameter value is obtained based on the first parameter value by index. There is no need for the preset calibration function to calculate the second parameter value according to the first parameter value. Different pair-data sets are called according to the service time of the sensor (1022), which reduces the error of the second parameter value and improves the reliability of the analyte detection device (102, 202, 302).
G01N 33/49 - Physical analysis of biological material of liquid biological material blood
G01N 33/00 - Investigating or analysing materials by specific methods not covered by groups
G01N 31/00 - Investigating or analysing non-biological materials by the use of the chemical methods specified in the subgroups; Apparatus specially adapted for such methods
A body fluid analyte detection device, includes: a transmitter, provided with at least one first fastener part; a bottom case, provided with at least one second fastener part corresponding to the first fastener part, and the bottom case including at least one fixed portion and at least one force-receiving portion. When separating the bottom case and the transmitter, the fixed portion is fixed and a force is applied to the force-receiving portion in one direction, separating the bottom case and the transmitter. The body fluid analyte detection device further includes a sensor connected with the transmitter to transmit the parameter signal; and a battery assembled in the bottom case or in the transmitter. The part holding the battery is the battery portion. A force is applied to the force-receiving portion in only one direction to make the bottom case fail and thereby separating the transmitter and the bottom case, simplifying user action and enhancing user experience.
A drug infusion device with elastic anti-reverse member comprises an infusion mechanism module(110), a control mechanism module(100), and an adhesive patch(120). The infusion mechanism module(110) includes a reservoir(131) used for accommodating the drug to be infused, a driving wheel assembly, a driving unit(1310) with a driving end(1312) that pushes the driving wheel(200) to rotate, a power unit(1311) and a reset unit(1320). The driving wheel assembly includes a driving wheel(200), a driving tube(204) and a cover(201). The cover(201) is used to fix the driving wheel(200) and also provided with at least one elastic member abutting against the driving wheel assembly. The power unit(1311) and the reset unit(1320) are connected with the driving unit(1310). The power unit(1311) exerts a force on the driving unit(1310) to make the driving wheel(200) move forward, and the reset unit(1320) exerts a force on the driving unit(1310) to reset the driving end(1312).That the elastic member is provided on cover(201) increases the compactness of the internal design.
An analyte detection device with intelligent identification function, includes: a transmitter; a sensor unit including a sensor base and a sensor with first parameter, and one end of the sensor inserted under the skin while the other end is installed in/on the sensor base; a bottom base; at least one physical unit with second parameter which corresponds to the first parameter arranged on the bottom base, on the sensor base or on/in the transmitter; and a detection circuit for detecting the second parameter which can be transmitted to the transmitter. Using this detection device, the transmitter can automatically identify the corresponding sensor information.
A61B 5/1473 - Measuring characteristics of blood in vivo, e.g. gas concentration, pH-value using chemical or electrochemical methods, e.g. by polarographic means invasive, e.g. introduced into the body by a catheter
A61B 5/00 - Measuring for diagnostic purposes ; Identification of persons
A high reliability analyte detection device includes: a bottom case; a sensor, assembled on the bottom case, including a signal output portion and a detection portion, and the signal output portion, which has a shape of a polyline or an arc toward the top of the bottom case provided with at least two first electrical connection ends insulated from each other; a transmitter, fastened with the bottom case provided with at least two second electrical connection ends which are insulated from each other and correspond to the first electrical connection ends, and one elastic member contacted with signal output portion, improving the electrical connection, thus enhancing the user experience.
A61B 5/145 - Measuring characteristics of blood in vivo, e.g. gas concentration, pH-value
A61B 5/1473 - Measuring characteristics of blood in vivo, e.g. gas concentration, pH-value using chemical or electrochemical methods, e.g. by polarographic means invasive, e.g. introduced into the body by a catheter
A61B 5/0215 - Measuring pressure in heart or blood vessels by means inserted into the body
A highly integrated intelligent analyte detection device, includes: a bottom case including a first connection region; a transmitter including a transmitter case and an internal circuit, the internal circuit including at least two second electrical connection ends and at least two first electrical connection ends, at least two first electrical connection ends electrically conductive; a sensor including a signal output portion and a detection portion, and the signal output portion provided with at least two third electrical connection ends; and a second connection region including at least two conductive areas and at least one insulation area, and at least two third electrical connection ends respectively electrically connected to the corresponding second electrical connection ends, reducing the complexity of internal structure in the device and the size of the device, thus enhancing the user experience.
A61B 5/145 - Measuring characteristics of blood in vivo, e.g. gas concentration, pH-value
B01L 3/00 - Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
A61B 5/00 - Measuring for diagnostic purposes ; Identification of persons
A61B 5/1468 - Measuring characteristics of blood in vivo, e.g. gas concentration, pH-value using chemical or electrochemical methods, e.g. by polarographic means
A highly integrated analyte detection device, includes: a bottom case; a sensor including a signal output portion and a detection portion; a transmitter provided with at least two second electrical connection ends which are corresponding to the first electrical connection ends; and a connection member, arranged between the first electrical connection ends and the second electrical connection ends, including at least two conductive areas and at least one insulation area. The insulation area is provided between two adjacent conductive areas, and at least two first electrical connection ends are respectively electrically connected to the corresponding second electrical connection ends.
An intelligent detection device. After the transmitter (12) is installed on the bottom case (10), the first physical device (122) on the transmitter housing (121) can be operatively electrically connected with the sensor (11) or the second physical device (1141) on the bottom case (10), and the internal circuit can obtain the in-position detection signal of the transmitter (12). Through the in-position detection signal, the firmness of the combination of the transmitter (12) and the bottom case (10) can be judged, which is convenient for users to take corresponding measures and enhance user experience.
A medical device with safety verification, comprising: a remote device; a functional device, the functional device can receive functional instructions from the remote device (100), the functional instructions include drug infusion instructions or non-infusion instructions; and a safety verification module installed in the functional device. After the safety verification module receives a verification instruction that matches the functional instruction, the functional device can execute the functional instruction; and the verification instruction includes the user's body movement. Before the medical device performs various functions, safety verification is required in order to improve the safety of the medical device.
A half-press-free drug infusion device, comprising a reservoir (131) configured to accommodate the drug to be infused, provided with a piston (312) and a screw (135); a driving wheel (134), connected with screw (135), driving the screw (135) to push the piston (312) forward by rotation; an infusion needle unit (521), including an infusion needle (5212) and an infusion needle holder (5211), wherein the infusion needle holder (5211) is used to keep the infusion needle (5212) in place, when leaving the factory, the infusion needle unit (521) is at the intermediate position, the infusion needle (5212) communicated with the reservoir (131); an adhesive patch (520), for attaching the infusion device module (510) to the skin surface; and security base (522), arranged on the bottom of the adhesive patch (520), provided with an infusion needle accommodating part (5220), which is waterproof and breathable. The user does not need to half-press the needle holder (5211) to the intermediate position, which reduces the user's operation steps, and as the priming process can be completed during the filling process, avoiding priming waiting, and shorting the user's operation period.
A body fluid analyte detection device, including an analyte detection module (100) for detecting analyte parameter information; a pasting module(13) comprises a tape(131) and a protective film(132), the first side(α) of the tape(131) is fixedly connected with the analyte detection module(100), and the second side(β) opposite the first side(α) of the tape(131) is coated with paste material; the protective film (132) is fixed around the outer edge of the first side(α) of the tape(131), and the outer edge profile of the protective film(132) is compatible with the outer edge profile of the tape(131), and the rockwell hardness of the protective film(132) is higher than the tape(131). The protective film(132) can prevent the edge of the tape(131) from warping, avoid displacement or shedding of detection devices when in use, ensure the normal use of the detection device, enhance the user's experience.
A micro analyte sensor is provided, which comprises a substrate (111), which comprises an internal part (X) and an external part (Y); A first electrode group (31) and a second electrode group (32), located on the surface of the internal part (X), each electrode group (31,32) including at least one working electrode (1131) and at least one additional electrode (1231,1331); In the external part (Y) is provided with pins (1111,1211,1311) corresponding to each electrode (1131,1231,1331), the pins (1111,1211,1311) are respectively electrically connected with the working electrode (1131) and the additional electrode (1231,1331) through a wire (1121,1221,1321); The first electrode group (31) and the second electrode group (32) are configured so that when in use, the first electrode group (31) detects the analyte at the first frequency and provides the first detection signal, and the second electrode group (32) detects the analyte at the second frequency and provides the redundant detection signal, and the first frequency is not less than the second frequency, improve the reliability of using detection device, enhance the user experience.
An analyte detection device with multilayer adhesive tape comprises: an analyte detection module is fixed on user's skin surface through an adhesive module, the adhesive module is equipped with at least N (N≥2) layers of the adhesive tape, the first side of the first layer of the adhesive tape is fixedly connected with the analyte detection module, and the rest of the adhesive tape is stacked on the first side of the first layer of the adhesive tape. The working time of the adhesive module can be extended and the user experience can be improved through relay use of the inner and outer adhesive tape one by one, and the outer adhesive tape delays the edge warping of the inner adhesive tape.
A61B 5/1473 - Measuring characteristics of blood in vivo, e.g. gas concentration, pH-value using chemical or electrochemical methods, e.g. by polarographic means invasive, e.g. introduced into the body by a catheter
A61B 5/145 - Measuring characteristics of blood in vivo, e.g. gas concentration, pH-value
100.
INTEGRATED CLOSED-LOOP ARTIFICIAL PANCREAS AND DATA OBTAINING METHOD FOR PROGRAM MODULE THEREOF
An integrated closed-loop artificial pancreas includes: a detection module; a program module which is imported into the total daily dose algorithm and the current insulin infusion algorithm; and an infusion module which is connected to the program module. The infusion module includes an infusion tube which is used as the insulin infusion channel, the detecting electrodes are provided on/in the wall of the infusion tube, and the infusion module can infuse insulin required according to the data of the current insulin infusion dose. It takes only one insertion to perform both glucose detection and insulin infusion.
G16H 20/17 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
G16H 40/63 - ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
